Indication for Splenectomy in the Era of Living-Donor Liver Transplantation

Transplantation Proceedings

Volumn 40, Issue 8, 2008, Pages 2531-2533

  Jeng, L B ^a   Lee, C C ^a   Chiang, H C ^a   Chen, T H ^a   Hsu, C H ^a   Cheng, H T ^a   Lai, H C ^a  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ASCITES; BLOOD GROUP ABO INCOMPATIBILITY; CADAVER; CLINICAL ARTICLE; FEMALE; HEPATITIS C; HUMAN; LIVER FUNCTION; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVING DONOR; MALE; PRIORITY JOURNAL; SPLENECTOMY; THROMBOCYTOPENIA; TREATMENT INDICATION;

ADULT; BILIRUBIN; CADAVER; FEMALE; HUMANS; LIVER FAILURE; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SPLENOMEGALY; TISSUE DONORS; TREATMENT OUTCOME;

EID: 53149088201     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.07.016     Document Type: Article

References (12)

1. Samimi F., Irish W.D., Eghtesad B., et al. Role of splenectomy in human liver transplantation under modern-day immunosuppression. Dig Dis Sci 43 (1998) 1931
2. Cescon M., Sugawara Y., Takayama T., et al. Role of splenectomy in living-donor liver transplantation for adult. Hepato-Gastroenterology 49 (2002) 721
3. Sato Y., Yamamoto S., Oya H., et al. Splenectomy for reduction of excessive portal hypertension after adult living-related donor liver transplantation. Hepato-Gastroenterology 49 (2002) 1652
4. Shimada M., Ijichi H., Yonemura Y., et al. The impact of splenectomy of splenic artery ligation on the outcome of a living donor adult liver transplantation using a left lobe graft. Hepato-Gastroenterology 51 (2004) 625
5. Kishi Y., Sugawara Y., Akamatsu N., et al. Splenectomy and preemptive interferon therapy for hepatitis C patients after living-donor liver transplantation. Clin Transplant 19 (2005) 769
6. Tashiro H., Itamoto T., Ohdan H., et al. Should splenectomy be performed for hepatitis C patients undergoing living-donor liver transplantation? 22 (2007) 959
7. Liu C.L., and Fan S.T. Adult-to-adult live-donor liver transplantation: the current status. J Hepatobiliary Pancreat Surg 13 (2006) 110
8. Egawa H., Oike F., Buhler L., et al. Impact of recipient age on outcome of ABO-incompatible living-donor liver transplantation. Transplantation 77 (2007) 403
9. Shimazu M., and Kitajima M. Living donor liver transplantation with special reference to ABO-incompatible grafts and small-for-size grafts. World J Surg 28 (2004) 2
10. Usuda M., Fujimori K., Koyamada N., et al. Succesful use of Anti-CD20 monoclonal antibody (Rituximab) for ABO-incompatible living-related liver transplantation. Transplantation 79 (2005) 12
11. Yoshizawa A., Sakamoto S., Ogawa K., et al. New protocol of immunosuppression for liver transplantation across ABO barrier: the use of Rituximab, hepatic arterial infusion, and preservation of spleen. Transplantation 37 (2005) 1718
12. Kozaki K., Egawa H., Usuda M., et al. The role of aphesis therapy for ABO incompatible living donor liver transplantation: the Kyoto university experience. Apher Dial 10 (2006) 441